A detailed history of Samsara Bio Capital, LLC transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 1,049,153 shares of BOLT stock, worth $535,068. This represents 0.39% of its overall portfolio holdings.

Number of Shares
1,049,153
Previous 1,049,153 -0.0%
Holding current value
$535,068
Previous $786,000 13.36%
% of portfolio
0.39%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.29 - $1.66 $1.35 Million - $1.74 Million
1,049,153 New
1,049,153 $1.46 Million
Q1 2022

May 16, 2022

BUY
$2.74 - $4.82 $854,041 - $1.5 Million
311,694 Added 42.27%
1,049,153 $2.88 Million
Q1 2021

May 18, 2021

BUY
$25.86 - $39.93 $19.1 Million - $29.4 Million
737,459 New
737,459 $24.3 Million

Others Institutions Holding BOLT

About Bolt Biotherapeutics, Inc.


  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $19.2M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.